Azenta (NASDAQ:AZTA) Releases Earnings Results, Beats Estimates By $0.08 EPS

Azenta (NASDAQ:AZTA) issued its quarterly earnings data on Tuesday. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.10 by $0.08, Briefing.com reports. The firm had revenue of $170.00 million during the quarter, compared to analysts’ expectations of $169.66 million. Azenta had a negative net margin of 25.01% and a positive return on equity of 0.98%. Azenta’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.13 earnings per share.

Azenta Trading Down 2.6 %

NASDAQ:AZTA traded down $1.14 during trading hours on Thursday, hitting $43.37. 152,995 shares of the company traded hands, compared to its average volume of 497,436. Azenta has a twelve month low of $40.24 and a twelve month high of $69.16. The firm has a 50-day moving average of $45.78 and a 200 day moving average of $50.59. The stock has a market capitalization of $2.12 billion, a price-to-earnings ratio of -14.99 and a beta of 1.48.

Insiders Place Their Bets

In other news, CFO Herman Cueto sold 1,595 shares of the company’s stock in a transaction dated Thursday, October 17th. The shares were sold at an average price of $43.68, for a total transaction of $69,669.60. Following the completion of the transaction, the chief financial officer now owns 24,604 shares of the company’s stock, valued at approximately $1,074,702.72. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.77% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on AZTA. Needham & Company LLC reduced their price objective on shares of Azenta from $69.00 to $55.00 and set a “buy” rating for the company in a research note on Wednesday. Evercore ISI decreased their price target on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a report on Tuesday, October 1st. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, Azenta currently has an average rating of “Hold” and a consensus price target of $63.60.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.